Skip to content

Insulin Detemir and Waist Circumference

Waist Circumference Reduction After Insulin Detemir Treatment in Type 2 Diabetes Patients Previously Treated With NPH Insulin

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00714844
Enrollment
20
Registered
2008-07-14
Start date
2007-01-31
Completion date
2007-10-31
Last updated
2008-07-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 2 Diabetes

Keywords

insulin therapy, insulin detemir, waist circumference

Brief summary

The purpose of the study is to investigate the weight-sparing effect of detemir and assess glycemic control and treatment satisfaction when switching from NPH to detemir, to improve metabolic control.

Interventions

None listed

Sponsors

University of Roma La Sapienza
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* Duration of type 2 diabetes for at least 12 months * BMI \<40 kg/m2 * HbA1c \>7.5% * Requiring basal insulin replacement and previously treated with NPH insulin

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026